You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR ULORIC

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ULORIC

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00102440 ↗	Febuxostat Versus Allopurinol Control Trial in Subjects With Gout	Completed	Takeda	Phase 3	2002-07-01	The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
NCT00174915 ↗	Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.	Completed	Takeda	Phase 3	2003-02-01	The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
NCT00174941 ↗	Long-Term Safety of Febuxostat in Subjects With Gout.	Completed	Takeda	Phase 2	2001-03-01	The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD), in maintaining serum urate levels within clinically acceptable levels in subjects with gout.
NCT00174967 ↗	Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout	Completed	Takeda	Phase 2	2001-01-01	The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ULORIC

Condition Name

Chart
Table

Condition Name for ULORIC
Intervention	Trials
Gout	14
Hyperuricemia	5
Hypertension	3
Chronic Kidney Disease	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ULORIC
Intervention	Trials
Gout	9
Hyperuricemia	9
Renal Insufficiency, Chronic	3
Kidney Diseases	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ULORIC

Trials by Country

Map
Table

Trials by Country for ULORIC
Location	Trials
United States	276
Mexico	8
Canada	6
China	3
Iceland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ULORIC
Location	Trials
California	11
Texas	11
Florida	10
North Carolina	9
Oklahoma	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ULORIC

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ULORIC
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	6
Phase 2	11
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ULORIC
Clinical Trial Phase	Trials
Completed	23
Terminated	2
Recruiting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ULORIC

Sponsor Name

Chart
Table

Sponsor Name for ULORIC
Sponsor	Trials
Takeda	15
Shanghai 10th People's Hospital	2
PAREXEL Early Phase Clinical Unit-Los Angeles	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ULORIC
Sponsor	Trials
Industry	20
Other	19
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.